J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Classificação em ações
#3899
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Preço da ação
$26.58
Última sincronização: 2026-07-23
Valor de mercado
$4.24B
Variação (1 dia)
0.00%
Variação (1 ano)
38.40%
País
IN
Negociar J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Categoria
Healthcare
Receita da J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Receita em Mar 2026 TTM: $457.75M
De acordo com os últimos relatórios financeiros da J. B. Chemicals & Pharmaceuticals Limited, a receita atual da empresa (TTM) é $457.75M. Em 2024, a empresa obteve uma receita de $417.85M um aumento em relação a a receita do ano 2023, que foi de $379.23M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da J. B. Chemicals & Pharmaceuticals Limited de 2005 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $457.75M | -0.08% |
| 2025 | $458.10M | 9.63% |
| 2024 | $417.85M | 10.19% |
| 2023 | $379.23M | 18.75% |
| 2022 | $319.36M | 16.55% |
| 2021 | $274.01M | 18.45% |
| 2020 | $231.33M | -0.24% |
| 2019 | $231.89M | 9.00% |
| 2018 | $212.73M | 5.28% |
| 2017 | $202.07M | 14.60% |
| 2016 | $176.33M | 4.91% |
| 2015 | $168.07M | 7.33% |
| 2014 | $156.59M | 8.27% |
| 2013 | $144.63M | -8.54% |
| 2012 | $158.14M | -16.27% |
| 2011 | $188.85M | 14.47% |
| 2010 | $164.98M | 16.80% |
| 2009 | $141.25M | 0.50% |
| 2008 | $140.54M | 15.92% |
| 2007 | $121.24M | 15.95% |
| 2006 | $104.56M | 27.21% |
| 2005 | $82.19M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 1,344.40% |
IN
|
